Clinical trials on ashwagandha use doses ranging from 240mg to 600mg of root extract per day — but the optimal dose varies by extract type, standardization, and health goal. This guide breaks down effective doses for stress, testosterone, sleep, and athletic performance with specific trial data.
An evidence-based ashwagandha dosage guide has to start with an important caveat: there is no single universal dose. Doses used in published clinical trials range from 120 mg to 600 mg of standardized root extract per day, and the dose that showed a significant effect in one well-designed trial may not match what another trial tested for a different outcome. The extract type and standardization also matter enormously — a raw root powder at 5,000 mg may deliver less active withanolide content than a standardized KSM-66 extract at 300 mg. Understanding these distinctions prevents the confusion that sends most supplement buyers to the wrong dose for the wrong reason.
Ashwagandha (Withania somnifera) is an Ayurvedic adaptogen with a growing evidence base in Western clinical research. Its primary active constituents are withanolides — steroidal lactones concentrated in the root — along with alkaloids and sitoindosides. The standardized extract KSM-66 (Ixoreal Biomed) is the most clinically studied form, with over 20 published human trials using the same root extract standardized to ≥5% withanolides. This standardization is why KSM-66 dosing is more precisely characterized than generic ashwagandha root powder dosing.
The Evidence Base
The clinical trial database for ashwagandha is larger than most people realize, though quality is variable. The most important trials for dosing guidance are those that used standardized extracts (primarily KSM-66 and Sensoril, which uses leaf and root), had placebo controls, and were independently published. Chandrasekhar et al. (2012) conducted the landmark stress and anxiety trial: 64 adults with chronic stress received 300 mg of KSM-66 twice daily (600 mg/day total) for 60 days. Serum cortisol dropped 27.9% versus placebo; the PSS (Perceived Stress Scale) score improved significantly. This trial established 600 mg/day as the core stress dose for KSM-66.
Ashwagandha dosing varies by goal and extract standardization. The table below maps dose ranges to evidence-backed outcomes:
| Daily Dose | Extract Standard | Primary Outcome | Evidence Strength | Best For |
|---|---|---|---|---|
| 300 mg | KSM-66 (5% withanolides) | Stress reduction | High | General wellness, beginners |
| 300–500 mg | KSM-66 or Sensoril | Cortisol reduction, sleep quality | High | Anxiety, HPA-axis support |
| 500–600 mg | KSM-66 | Strength & muscle recovery | Moderate–High | Athletes, resistance training |
| 600 mg | KSM-66 | Testosterone support, fertility | Moderate | Men 30+, reproductive health |
| 125 mg (Sensoril) | Sensoril (10% withanolides) | Cognitive function, memory | Moderate | Focus, cognitive performance |
Langade et al. (2019) used 300 mg of KSM-66 twice daily (600 mg/day) in a trial specifically focused on sleep quality and anxiety, finding significant improvements in sleep quality scores, sleep onset latency, and total sleep time versus placebo. Wankhede et al. (2015) used 300 mg twice daily in resistance-trained men, finding significant improvements in bench press strength, leg extension strength, and muscle recovery over 8 weeks. Choudhary et al. (2017) used 300 mg twice daily for cognitive function improvement, finding significant improvements in immediate memory, general memory, executive function, and processing speed at 8 weeks.
What is notable across these trials is the consistency of the dose: 300 mg twice daily (600 mg total) of KSM-66 appears across multiple indication-specific trials. This is not coincidence — it is the dose for which the most evidence has been generated because it is the dose range where the extract producer funded the initial validation research. The dose is well-supported, but it also means the evidence base is largely industry-linked and concentrated at a single dose point.
The Mechanism
Ashwagandha's primary mechanisms are mediated through the HPA (hypothalamic-pituitary-adrenal) axis and the immune-inflammatory axis. Withanolides act as partial agonists at glucocorticoid receptors and also modulate the stress-sensing pathways upstream. The net effect is a blunting of cortisol peak amplitude and normalization of the cortisol awakening response without suppression of the normal diurnal cortisol rhythm. This distinguishes ashwagandha from pharmaceutical anxiolytics that broadly suppress cortisol or HPA signaling — adaptogens modulate the stress response rather than suppressing it.
Pratte et al. (2014) reviewed the full body of human trial data for ashwagandha anxiety effects, finding consistent benefit across multiple trial designs and extract types, though they noted methodological limitations in several studies. The withanolide mechanism also explains the testosterone-related effects observed in male subjects: cortisol and testosterone exist in inverse relationship, and chronic HPA overactivation suppresses gonadal testosterone production (the cortisol-testosterone seesaw). By attenuating cortisol excess, ashwagandha may restore testosterone toward its natural range in men with stress-induced suppression — not by directly stimulating testosterone synthesis, but by removing the suppressive influence of elevated cortisol.
Dose by Health Goal: What the Trials Show
Stress and Anxiety: 300–600 mg/day KSM-66 (or equivalent standardized extract)
The Chandrasekhar 2012 trial at 600 mg/day is the strongest evidence for stress-specific dosing. A 300 mg/day single-dose study has also shown benefit, though effect sizes are smaller. If tolerating 600 mg/day is an issue (some users report drowsiness at the full dose initially), beginning with 300 mg/day and titrating to 600 mg/day over 2–3 weeks is a reasonable clinical approach. In studies using Sensoril (a leaf + root extract standardized to 10% withanolides), effective doses are lower — 125–250 mg/day — because withanolide density is higher per gram.
Sleep Quality: 300–600 mg/day KSM-66, taken in the evening or split AM/PM
The Langade 2019 trial used 300 mg twice daily in adults with self-reported insomnia and anxiety. Sleep improvements were robust — significant reductions in sleep onset latency and improvements in sleep quality scores. For people who use ashwagandha primarily for sleep, taking the larger portion (or full dose) in the evening 1–2 hours before bed may optimize the sedative-calming component. Unlike pharmaceutical sleep aids, ashwagandha's sleep benefit appears to be mediated through anxiety reduction and cortisol normalization rather than direct sedation — consistent with the mechanism.
Athletic Performance and Recovery: 300–600 mg/day KSM-66, taken consistently
The Wankhede 2015 trial found significant strength and muscle recovery improvements at 300 mg twice daily over 8 weeks in resistance-trained men. Liao et al. supplemented recreational runners with NMN rather than ashwagandha, but the recovery mechanism — reduced cortisol-mediated catabolism — is analogous. For athletic use, the timing of ashwagandha relative to training likely matters less than consistent daily dosing; the mechanism operates through chronic HPA axis normalization, not acute pre-workout signaling. Bio:sudo KSM-66 Reishi Restore provides 600 mg KSM-66 in a daily dose, consistent with the trial data for athletic and performance use.
Testosterone and Male Hormonal Health: 300–600 mg/day KSM-66
Evidence for ashwagandha and testosterone is more limited. The most cited trial (Wankhede 2015) found testosterone improvements as a secondary endpoint in resistance-trained men, with a mean increase of about 96 ng/dL versus placebo — clinically meaningful if sustained, though the trial was 8 weeks. It is important to contextualize this: these were men under training stress, and the testosterone increase likely reflects HPA axis normalization rather than a direct androgen effect. Men with normal HPA axis function who are not experiencing stress-related testosterone suppression are less likely to see significant testosterone changes. Setting expectations at "may help restore stress-suppressed testosterone toward natural range" rather than "boosts testosterone" is the accurate frame.
Extract Type and Standardization: Why This Matters More Than Dose Number
The ashwagandha supplement market is saturated with products ranging from raw root powder at 500–1000 mg per capsule to highly standardized extracts at 120–300 mg. These products are not dose-equivalent. A raw root powder with 0.2% withanolide content delivers 2 mg of withanolides per 1000 mg capsule. KSM-66 standardized to 5% withanolides delivers 15 mg per 300 mg capsule — 7.5x more active compound per gram of extract. Sensoril at 10% withanolides delivers even more per gram.
When you see a bottle claiming "1,000 mg ashwagandha extract" with no standardization information, you cannot know whether the dose is therapeutically relevant. The clinical trials that show consistent benefit use standardized extracts where the withanolide content is verified and consistent lot-to-lot. This is not a trivial quality difference — it is the difference between a dose with a known biological effect and an undetermined quantity of active compound.
For a detailed comparison of extract types and what to look for on a supplement label, see our KSM-66 vs Regular Ashwagandha breakdown and our guide on How to Choose an Ashwagandha Extract.
Timing, Duration, and Cycling
Timing: Ashwagandha can be taken once daily or divided into two doses. For sleep benefits, concentration of the dose in the evening makes physiological sense given the cortisol-modulating mechanism. For general stress and athletic performance, consistent daily dosing matters more than timing. Taken with food reduces the likelihood of GI discomfort, which some users experience on an empty stomach.
Duration: Published trials have run 6–12 weeks. Meaningful effects on stress, sleep, and strength take at minimum 4–6 weeks to manifest because the mechanism operates through chronic HPA normalization, not acute neurotransmitter signaling. Starting at week 2 and expecting dramatic results is setting up for disappointment and early discontinuation before the intervention has had time to work.
Cycling: Whether ashwagandha requires cycling (periodic cessation to prevent tolerance) is not well characterized in the human literature. The Ayurvedic tradition suggests cycling (use for several months, rest for one month), but no controlled human data quantifies tolerance development. A practical approach is to use continuously for 3–4 months, take a 2–4 week break to reassess baseline, and resume if subjective and objective markers (HRV, sleep quality, self-reported stress) remain improved versus pre-supplementation baseline.
The Ashwagandha Side Effects guide covers contraindications and the rare but documented cases of hepatotoxicity associated with very high doses (typically well above standard clinical doses), which is relevant context for anyone considering doses above the 600 mg/day range.
Who Benefits Most
The evidence base is strongest for three groups: adults experiencing chronic psychological stress with elevated cortisol, anxiety, and sleep disruption — this is the core clinical indication with the most robust trial data; resistance-trained athletes or physically active adults seeking improved recovery metrics and reduced stress-mediated catabolism; and men with training- or stress-related testosterone suppression who want to normalize the cortisol-testosterone axis without pharmacological intervention. People without significant HPA axis dysregulation (healthy, low-stress adults with normal sleep) will see smaller average effects — not because the supplement doesn't work, but because there is less biological disruption to correct.
Practical Takeaways
- 300–600 mg/day of KSM-66 (standardized to ≥5% withanolides) is the dose range with the strongest clinical evidence across stress, sleep, and athletic performance trials
- Extract type matters as much as dose number — always check for standardization information; "1000 mg ashwagandha" without standardization tells you very little
- Allow 4–6 weeks minimum before evaluating effectiveness; HPA axis normalization is a chronic process, not an acute one
- For sleep, take the larger dose (or full dose) 1–2 hours before bed; for athletic recovery, timing relative to training matters less than daily consistency
- Testosterone effects, where present, likely reflect stress-mediated suppression correction — not direct androgenic stimulation
- Consider cycling after 3–4 months of continuous use to reassess baseline, though tolerance data in humans is limited
Bottom Line
The clinical trial evidence for ashwagandha concentrates around 300–600 mg/day of KSM-66 root extract (standardized to ≥5% withanolides), and this dose is consistently effective across stress, sleep quality, and athletic recovery endpoints in controlled human trials. Sensoril (leaf + root, 10% withanolides) achieves comparable effects at 125–250 mg/day due to higher withanolide density. The most important variable is not whether you take 300 mg or 600 mg — it is whether the supplement you buy uses a standardized extract with verified withanolide content. Raw root powder without standardization at any dose is an unreliable delivery vehicle. Bio:sudo KSM-66 Reishi Restore provides the evidence-supported 600 mg KSM-66 dose with full COA documentation confirming extract quality.
References
- Chandrasekhar K, et al. "A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of ashwagandha root in reducing stress and anxiety in adults." Indian J Psychol Med. 2012;34(3):255–262. [Source]
- Langade D, et al. "Efficacy and safety of ashwagandha root extract in insomnia and anxiety." Medicine. 2019;98(37):e17186. [Source]
- Wankhede S, et al. "Examining the effect of Withania somnifera supplementation on muscle strength and recovery." J Int Soc Sports Nutr. 2015;12:43. [Source]
- Choudhary D, et al. "Efficacy and safety of ashwagandha root extract in improving memory and cognitive functions." J Dietary Suppl. 2017;14(6):599–612. [Source]
- Pratte MA, et al. "An alternative treatment for anxiety: a systematic review of human trial results reported for the Ayurvedic herb ashwagandha." J Altern Complement Med. 2014;20(12):901–908. [Source]
Try This Protocol
KSM-66® ashwagandha 600 mg · clinically studied extract · COA available
Shop Now →